These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 326387)

  • 21. Editorial: Antiestrogens and breast cancer treatment.
    Carbone PP
    Ann Intern Med; 1975 Nov; 83(5):730-1. PubMed ID: 173220
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic value of nafoxidine hydrochloride in the treatment of advanced carcinoma of the human breast.
    Sasaki GH; Leung BS; Fletcher WS
    Surg Gynecol Obstet; 1976 Apr; 142(4):560-4. PubMed ID: 1257870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.
    Engelsman E; Heuson JC; Blonk Van Der Wijst J; Drochmans A; Maass H; Cheix F; Sobrinho LG; Nowakowski H
    Br Med J; 1975 Jun; 2(5973):714-5. PubMed ID: 1095122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of breast cancers with antiestrogens. Clinical study of nafoxidine].
    Metz R; Bey P
    Nouv Presse Med; 1977 Dec; 6(44):4145-6. PubMed ID: 600772
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen-stimulated growth of human endometrial carcinoma.
    Jordan VC; Gottardis MM; Satyaswaroop PG
    Ann N Y Acad Sci; 1991; 622():439-46. PubMed ID: 1905895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal and molecular structure of nafoxidine and stereochemical features of anticancer antiestrogens.
    Camerman N; Chan LY; Camerman A
    J Med Chem; 1980 Aug; 23(8):941-5. PubMed ID: 7401119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiestrogens.
    Devi PK
    Pharmacol Ther; 1981; 12(3):439-47. PubMed ID: 7025028
    [No Abstract]   [Full Text] [Related]  

  • 29. Tamoxifen (antiestrogen) therapy in advanced breast cancer.
    Kiang DT; Kennedy BJ
    Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells.
    Strobl JS; Monaco ME; Lippman ME
    Endocrinology; 1980 Aug; 107(2):450-60. PubMed ID: 7389663
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
    Lopes MC; Tavares MC; Vale MG; Carvalho AP
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):343-52. PubMed ID: 1911424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer.
    Leclercq G; Devleeschouwer N; Heuson JC
    J Steroid Biochem; 1983 Jul; 19(1A):75-85. PubMed ID: 6887875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiestrogen therapy of breast cancer.
    Lippman ME
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):11-9. PubMed ID: 6367050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [3-H]estradiol by brain cell nuclei and female rat sexual behavior: inhibition by antiestrogens.
    Roy EJ; Wade GN
    Brain Res; 1977 Apr; 126(1):73-87. PubMed ID: 856418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of uterine ornithine decarboxylase (ODC) by antiestrogens. Inhibition of estradiol-mediated induction of ODC: a possible mechanism of action of antiestrogens.
    Bulger WH; Kupfer D
    Endocr Res Commun; 1976; 3(3-4):209-18. PubMed ID: 964206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V; Jensen EV; Knabbe C
    Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects and mechanism of action of antiestrogens in breast cancer].
    Borgna JL; Rochefort H
    Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifactorial activities of nonsteroidal antiestrogens against leukemia.
    Hayon T; Atlas L; Levy E; Dvilansky A; Shpilberg O; Nathan I
    Cancer Detect Prev; 2003; 27(5):389-96. PubMed ID: 14585326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.
    Horwitz KB; Mockus MB; Lessey BA
    Cell; 1982 Mar; 28(3):633-42. PubMed ID: 7200400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.